NCT01681173
- Conditions
- Body Weight, Body Weight Changes, Diabetes, +16 more
- Locations
-
- German Instiute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany
- Charite University Berlin, State of Berlin, Germany
Clinical trial condition
Glucose Metabolism Disorders
Explore clinical trials studying Glucose Metabolism Disorders. Study availability and eligibility vary by location and protocol.
134 public trials
16 recruiting studies
Glucose Metabolism Disorders trial results
Completed
Effect of Pioglitazone Versus Metformin on Bone Health in Postmenopausal Women With Type 2 Diabetes
NCT01935804
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Center of Excellence for Osteoporosis Research, King Abdulaziz University Jeddah, Mecca Region, Saudi Arabia
NCT01452958
- Conditions
- Glucose Metabolism Disorders, Hyperinsulinism, Inflammation, +5 more
- Locations
-
- Medical Department MEA, NBG, Aarhus University Hospital Aarhus, Denmark
NCT01757756
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Pfizer Investigational Site South Miami, Florida, United States
NCT00192621
- Conditions
- Blood-Borne Infections, Cardiovascular Disease, Cardiovascular Diseases, +22 more
- Locations
-
- St Vincents Hospital Sydney, New South Wales, Australia
NCT01369277
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Pfizer Investigational Site New Haven, Connecticut, United States
NCT00114855
- Conditions
- Dyslipidemias, Glucose Metabolism Disorders, Hyperlipidemia, +4 more
- Locations
-
- Lipidklinikken, Rikshospitalet Oslo, Norway
NCT01129258
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Pfizer Investigational Site Chula Vista, California, United States
- Pfizer Investigational Site Fountain Valley, California, United States
- Pfizer Investigational Site Miami, Florida, United States
- Pfizer Investigational Site San Antonio, Texas, United States
NCT01102673
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Pfizer Investigational Site New Haven, Connecticut, United States
Completed
The DREAM (Diabetes Reduction Assessment With Ramipril and Rosiglitazone Medication) Trial
NCT00095654
- Conditions
- Cardiovascular Disease, Cardiovascular Diseases, Glucose Intolerance, +5 more
- Locations
-
Not specified